Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Pharmaceuticals, Qiagen

Premium

Genaissance Pharmaceuticals has launched its Familion test for cardiac channelopathies. The test confirms the presence of mutations known to cause these life-threatening conditions, which include Long QT and Brugada Syndromes. There are five of these mutations.

Before Familion was released, cardiologists identified individuals at risk for channelopathies by performing an electrocardiogram — which is “difficult and may be overlooked,” Genaissance said.

Besides developing the test as a diagnostic tool for pediatric cardiologists and electrophysiologists, Genaissance said it hopes to sell the product along with the company’s haplotype technology to drug makers, which would use the test in clinical trials as a way to avoid drug-induced Long QT problems.

Drugs known to increase an individual’s risk of developing a prolonged QT interval include certain antibiotics, antidepressants, antihistamines, diuretics, cardiac drugs, antihypercholesterolemia drugs, insulin, antifungals, and antipsychotics.

Read more about the Familion test in the 4/8/04 PGx Reporter.


Qiagen has released Version 3.0 of its Array-Ready Oligo Set for the rat genome. The product contains 26,962 70-mer probes, representing 22,012 genes and 27,044 gene transcripts, the company said.

The new Rat AROS uses data from the Ensembl Rat 19.3b.2 database, which is based on the Rat Genome Sequencing Project.

 

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.